Name | Number of supported studies | Average coverage | |
---|---|---|---|
B cell | 7 studies | 20% ± 6% | |
connective tissue cell | 7 studies | 24% ± 9% | |
endothelial cell | 7 studies | 30% ± 14% | |
oligodendrocyte precursor cell | 7 studies | 33% ± 15% | |
fibroblast | 6 studies | 24% ± 6% | |
epithelial cell | 6 studies | 36% ± 15% | |
astrocyte | 6 studies | 31% ± 12% | |
natural killer cell | 5 studies | 17% ± 2% | |
myofibroblast cell | 5 studies | 25% ± 5% | |
neuron | 5 studies | 30% ± 15% | |
pericyte | 5 studies | 24% ± 6% | |
basal cell | 5 studies | 23% ± 11% | |
oligodendrocyte | 5 studies | 32% ± 7% | |
CD16-negative, CD56-bright natural killer cell, human | 4 studies | 18% ± 1% | |
microglial cell | 4 studies | 26% ± 3% | |
precursor B cell | 4 studies | 29% ± 7% | |
pro-B cell | 4 studies | 29% ± 8% | |
retina horizontal cell | 4 studies | 18% ± 2% | |
retinal cone cell | 4 studies | 19% ± 4% | |
Mueller cell | 4 studies | 21% ± 2% | |
GABAergic neuron | 4 studies | 61% ± 11% | |
glutamatergic neuron | 4 studies | 59% ± 24% | |
naive B cell | 4 studies | 20% ± 3% | |
progenitor cell | 3 studies | 26% ± 4% | |
abnormal cell | 3 studies | 24% ± 2% | |
interneuron | 3 studies | 42% ± 16% | |
macrophage | 3 studies | 25% ± 5% | |
smooth muscle cell | 3 studies | 23% ± 2% | |
endothelial cell of lymphatic vessel | 3 studies | 16% ± 1% | |
immature B cell | 3 studies | 22% ± 4% | |
ciliated cell | 3 studies | 30% ± 10% | |
secretory cell | 3 studies | 18% ± 2% | |
regulatory T cell | 3 studies | 18% ± 3% | |
goblet cell | 3 studies | 23% ± 6% | |
plasmacytoid dendritic cell | 3 studies | 23% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 6378.19 | 21 / 21 | 100% | 43.34 | 504 / 504 |
breast | 100% | 6638.26 | 459 / 459 | 100% | 45.83 | 1118 / 1118 |
esophagus | 100% | 5343.65 | 1445 / 1445 | 100% | 42.31 | 183 / 183 |
uterus | 100% | 10845.69 | 170 / 170 | 100% | 49.95 | 459 / 459 |
lung | 100% | 5436.13 | 578 / 578 | 100% | 40.70 | 1153 / 1155 |
ovary | 100% | 11664.45 | 180 / 180 | 100% | 38.52 | 429 / 430 |
prostate | 100% | 8090.80 | 245 / 245 | 99% | 35.20 | 499 / 502 |
brain | 99% | 4468.92 | 2619 / 2642 | 100% | 44.71 | 704 / 705 |
thymus | 100% | 8748.46 | 653 / 653 | 99% | 49.31 | 598 / 605 |
pancreas | 100% | 4171.90 | 328 / 328 | 98% | 36.34 | 175 / 178 |
intestine | 100% | 7468.68 | 966 / 966 | 98% | 30.10 | 517 / 527 |
adrenal gland | 100% | 6059.52 | 258 / 258 | 98% | 26.66 | 225 / 230 |
stomach | 100% | 5275.05 | 359 / 359 | 98% | 30.32 | 279 / 286 |
kidney | 100% | 5533.92 | 89 / 89 | 96% | 31.23 | 863 / 901 |
skin | 100% | 4108.17 | 1805 / 1809 | 90% | 28.60 | 426 / 472 |
liver | 100% | 3093.42 | 226 / 226 | 84% | 17.08 | 343 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 29.68 | 29 / 29 |
spleen | 100% | 9436.19 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 31.58 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 20.27 | 1 / 1 |
adipose | 100% | 4801.86 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 5302.59 | 1333 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 3115.57 | 851 / 861 | 0% | 0 | 0 / 0 |
muscle | 98% | 2346.21 | 787 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 75% | 2435.51 | 694 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 56% | 14.89 | 45 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006397 | Biological process | mRNA processing |
GO_0034063 | Biological process | stress granule assembly |
GO_1903608 | Biological process | protein localization to cytoplasmic stress granule |
GO_0000381 | Biological process | regulation of alternative mRNA splicing, via spliceosome |
GO_1904037 | Biological process | positive regulation of epithelial cell apoptotic process |
GO_0008380 | Biological process | RNA splicing |
GO_0048024 | Biological process | regulation of mRNA splicing, via spliceosome |
GO_0001818 | Biological process | negative regulation of cytokine production |
GO_0006915 | Biological process | apoptotic process |
GO_0017148 | Biological process | negative regulation of translation |
GO_0097165 | Cellular component | nuclear stress granule |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_1990904 | Cellular component | ribonucleoprotein complex |
GO_0010494 | Cellular component | cytoplasmic stress granule |
GO_0005634 | Cellular component | nucleus |
GO_0008143 | Molecular function | poly(A) binding |
GO_0035925 | Molecular function | mRNA 3'-UTR AU-rich region binding |
GO_0003723 | Molecular function | RNA binding |
GO_0003730 | Molecular function | mRNA 3'-UTR binding |
GO_0005515 | Molecular function | protein binding |
Gene name | TIA1 |
Protein name | Cytotoxic granule associated RNA binding protein TIA1 (Nucleolysin TIA-1 isoform p40) (RNA-binding protein TIA-1) (T-cell-restricted intracellular antigen-1) (TIA-1) (p40-TIA-1) Alternative protein TIA1 TIA1 cytotoxic granule associated RNA binding protein |
Synonyms | |
Description | FUNCTION: RNA-binding protein involved in the regulation of alternative pre-RNA splicing and mRNA translation by binding to uridine-rich (U-rich) RNA sequences . Binds to U-rich sequences immediately downstream from a 5' splice sites in a uridine-rich small nuclear ribonucleoprotein (U snRNP)-dependent fashion, thereby modulating alternative pre-RNA splicing . Preferably binds to the U-rich IAS1 sequence in a U1 snRNP-dependent manner; this binding is optimal if a 5' splice site is adjacent to IAS1 (By similarity). Activates the use of heterologous 5' splice sites; the activation depends on the intron sequence downstream from the 5' splice site, with a preference for a downstream U-rich sequence . By interacting with SNRPC/U1-C, promotes recruitment and binding of spliceosomal U1 snRNP to 5' splice sites followed by U-rich sequences, thereby facilitating atypical 5' splice site recognition by U1 snRNP . Activates splicing of alternative exons with weak 5' splice sites followed by a U-rich stretch on its own pre-mRNA and on TIAR mRNA (By similarity). Acts as a modulator of alternative splicing for the apoptotic FAS receptor, thereby promoting apoptosis . Binds to the 5' splice site region of FAS intron 5 to promote accumulation of transcripts that include exon 6 at the expense of transcripts in which exon 6 is skipped, thereby leading to the transcription of a membrane-bound apoptotic FAS receptor, which promotes apoptosis . Binds to a conserved AU-rich cis element in COL2A1 intron 2 and modulates alternative splicing of COL2A1 exon 2 . Also binds to the equivalent AT-rich element in COL2A1 genomic DNA, and may thereby be involved in the regulation of transcription . Binds specifically to a polypyrimidine-rich controlling element (PCE) located between the weak 5' splice site and the intronic splicing silencer of CFTR mRNA to promote exon 9 inclusion, thereby antagonizing PTB1 and its role in exon skipping of CFTR exon 9 . Involved in the repression of mRNA translation by binding to AU-rich elements (AREs) located in mRNA 3' untranslated regions (3' UTRs), including target ARE-bearing mRNAs encoding TNF and PTGS2 (By similarity). Also participates in the cellular response to environmental stress, by acting downstream of the stress-induced phosphorylation of EIF2S1/EIF2A to promote the recruitment of untranslated mRNAs to cytoplasmic stress granules (SGs), leading to stress-induced translational arrest . Formation and recruitment to SGs is regulated by Zn(2+) (By similarity). Possesses nucleolytic activity against cytotoxic lymphocyte target cells . .; FUNCTION: [Isoform Short]: Displays enhanced splicing regulatory activity compared with TIA isoform Long. . |
Accessions | ENST00000433529.7 [P31483-1] P31483 H7BY49 ENST00000282574.8 ENST00000361692.4 ENST00000415783.6 [P31483-2] ENST00000474809.6 F8W8I6 E5RGV5 ENST00000416149.6 [P31483-3] ENST00000454815.6 ENST00000445587.5 L8E940 C9JTN7 F8WE16 |